These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 7878881

  • 21. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML, Shaffer D, Ohzato H, Gottschalk R, Van der Werf WJ, Monaco AP.
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract] [Full Text] [Related]

  • 22. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y, Matsuura T, Imanishi M, Tahara H, Kurita T.
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract] [Full Text] [Related]

  • 23. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
    Yu S, Nakafusa Y, Flye MW.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
    [No Abstract] [Full Text] [Related]

  • 24. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J, Sayegh MH, Watschinger B, Hancock WW, Kupiec-Weglinski JW.
    Transplantation; 1994 Jul 15; 58(1):80-6. PubMed ID: 8036712
    [Abstract] [Full Text] [Related]

  • 25. Induction of tolerance in rat cardiac allograft model by intrathymic injection of donor bone marrow cells.
    Ito A, Ito T, Kamiike W, Nozaki S, Uchikoshi F, Tanaka T, Kuhara A, Moriguchi A, Miyata M, Nakata S.
    Transplant Proc; 1995 Apr 15; 27(2):1607-8. PubMed ID: 7536974
    [No Abstract] [Full Text] [Related]

  • 26. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW.
    Surgery; 2000 Aug 15; 128(2):206-12. PubMed ID: 10922993
    [Abstract] [Full Text] [Related]

  • 27. Effects of delayed intrathymic donor splenocyte infusion on cardiac allograft survival in antilymphocyte serum-treated rats.
    Light BW, Rivas P, Blanchard JM, Tetali S, Chou D, Lazda VA, Pollak R.
    Transplantation; 1995 Feb 15; 59(3):429-32. PubMed ID: 7871576
    [No Abstract] [Full Text] [Related]

  • 28. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
    Xia W, Sayegh MH, Kirkman RL.
    Transplant Proc; 1994 Jun 15; 26(3):1581. PubMed ID: 8030045
    [No Abstract] [Full Text] [Related]

  • 29. Induction of antigen-specific tolerance: antigen form and injection route.
    Yoshimura N, Hamashima T, Oka T.
    Transplant Proc; 1996 Jun 15; 28(3):1150-1. PubMed ID: 8658604
    [No Abstract] [Full Text] [Related]

  • 30. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
    Nagano H, Monden M, Gotoh M, Tanigawa T, Nakano Y, Tono T, Mori T.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):352-3. PubMed ID: 8438331
    [No Abstract] [Full Text] [Related]

  • 31. Prolongation of small bowel allografts after intrathymic injection of donor alloantigen and ALS.
    Goss JA, Nakafusa Y, Flye MW.
    J Surg Res; 1993 May 15; 54(5):494-8. PubMed ID: 8361174
    [Abstract] [Full Text] [Related]

  • 32. Portal tolerance in rats: effect of donor cell treatment and timing of administration.
    Tanigawa T, Monden M, Nagano H, Hasuike Y, Gotoh M, Fukuzaki T, Ota H, Yoshida T, Mori T.
    Transplant Proc; 1994 Aug 15; 26(4):1870-1. PubMed ID: 8066608
    [No Abstract] [Full Text] [Related]

  • 33. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF, Jin MX, Chowdhury NC, Ohajekwe OA.
    Transplantation; 1994 Nov 27; 58(10):1077-81. PubMed ID: 7974714
    [Abstract] [Full Text] [Related]

  • 34. Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allografts.
    Schulak JA, Mulligan DC, Robinson A.
    Transplant Proc; 1997 Nov 27; 29(1-2):1070-1. PubMed ID: 9123203
    [No Abstract] [Full Text] [Related]

  • 35. Effect of antilymphocyte serum, donor antigen, and graft irradiation on rat pancreas allograft survival.
    Herrmann MJ, Schulak JA.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 1):489-90. PubMed ID: 1990595
    [No Abstract] [Full Text] [Related]

  • 36. Prolongation of cardiac allograft survival in rats by immunization with antibody-coated blood cells: changes in the T-cell compartment.
    Terness P, Thies JC, Koru T, Daniel V, Otto G, Süsal C, Opelz G.
    Transplant Proc; 1992 Dec 27; 24(6):2562-4. PubMed ID: 1465867
    [No Abstract] [Full Text] [Related]

  • 37. Xenograft tolerance induced by intrathymic spleen cell injection.
    Sheffield CD, Hadley GH, Bartlett ST.
    Transplant Proc; 1994 Jun 27; 26(3):1204. PubMed ID: 8029887
    [No Abstract] [Full Text] [Related]

  • 38. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H, Monaco AP.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract] [Full Text] [Related]

  • 39. A unique mechanism of tolerance by perioperative intrathymic injection of bone marrow cells with a short course of ALS and FK506 in the rat cardiac allograft model.
    Ito A, Ito T, Kamiike W, Moriguchi A, Ohkawa A, Uchikoshi F, Tanaka S, Nakata S, Matsuda H.
    Transplant Proc; 1997 Feb 27; 29(1-2):1137-8. PubMed ID: 9123237
    [No Abstract] [Full Text] [Related]

  • 40. Donor-soluble histocompatibility antigen selectively potentiates suppressor elements while decreasing the frequency of alloantigen-specific T cytotoxic cells.
    Stepkowski SM, Ghobrial R, Wang B, Ito Y, Goto S, Hamashima T, Kahan BD.
    Transplant Proc; 1993 Oct 27; 25(5):2875. PubMed ID: 8212270
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.